Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_assertion type Assertion NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_head.
- NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_assertion description "[The Seipin/BSCL2 gene was originally identified as a loss-of-function gene for congenital generalized lipodystrophy type 2 (CGL2), a condition characterized by severe lipoatrophy, insulin resistance, hypertriglyceridaemia and mental retardation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_provenance.
- NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_assertion evidence source_evidence_literature NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_provenance.
- NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_assertion SIO_000772 18790819 NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_provenance.
- NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_assertion wasDerivedFrom befree-20140225 NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_provenance.
- NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_assertion wasGeneratedBy ECO_0000203 NP929281.RA442k5WFhm2vNoR3nYVU0ef--ovTEIWMDwJnC1KomUHY130_provenance.